New study aims to crack Tough-to-Diagnose joint diseases

NCT ID NCT06312943

Recruiting now Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is collecting joint fluid and tissue samples from 50 adults with inflammatory or non-inflammatory bone and joint diseases. Researchers will use both standard and advanced lab techniques to find new biomarkers that could help diagnose rheumatic diseases more accurately and earlier, especially in cases where current methods fail.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to more accurate and earlier diagnoses for hard-to-classify rheumatic diseases.
What could go wrong: This is a small, early-stage observational study (50 participants) focused on lab analysis, not a treatment trial. The new methods may not prove reliable enough for routine use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLAMMATORY AND NON-INFLAMMATORY BONE AND JOINT DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

arthropathy osteoarthritis rheumatic disorder rheumatoid arthritis skeletal system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INFLAMMATORY AND NON-INFLAMMATORY BONE AND JOINT DISEASES

Contacts and locations

Locations

Service de Médecine Physique et de Réadaptation, Hôpital Cochin
RECRUITING

Paris, IDF, 75014, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.